Key Points
Riverstone Holdings reports earnings May 13 at S$0.73 with 14.6 PE ratio.
Company shows 30% net income growth and 17.3% revenue expansion in FY2024.
Stock offers 11.7% dividend yield but faces technical oversold conditions.
Meyka AI rates AP4.SI as B-grade HOLD with mixed long-term forecast signals.
Riverstone Holdings Limited (AP4.SI) will announce earnings on May 13, 2026 on the Singapore Exchange (SES). The healthcare glove manufacturer trades at S$0.73 with a PE ratio of 14.6 and an impressive 11.7% dividend yield. AP4.SI stock has declined 0.68% today on moderate volume of 1.29 million shares. The company manufactures cleanroom and healthcare gloves, serving semiconductor and medical industries across Asia, Europe, and the Americas. With a market cap of S$1.08 billion, Riverstone is a key player in medical consumables. Investors are watching this earnings report closely as the company has shown strong fundamentals with zero debt and solid cash generation.
AP4.SI Stock Performance and Valuation
Riverstone Holdings trades at S$0.73 on the SES, down 0.68% intraday from S$0.735 open. The stock has retreated 21.9% over the past year but remains above its 52-week low of S$0.635. Year-to-date, AP4.SI stock has fallen 16.1%, reflecting broader healthcare sector pressures.
The valuation metrics show mixed signals. At a PE of 14.6, Riverstone trades below the healthcare sector average of 22.2. The price-to-book ratio of 2.26 suggests the market values the company at a modest premium. Earnings per share stand at S$0.05, while the stock yields 11.7% in dividends, making it attractive for income investors. The company maintains a fortress balance sheet with zero debt and a current ratio of 9.23, indicating exceptional liquidity.
Financial Strength and Growth Trajectory
Riverstone’s fundamentals remain robust heading into the May 13 earnings announcement. The company generated S$0.205 in operating cash flow per share and S$0.149 in free cash flow per share over the trailing twelve months. Return on equity stands at 13.2%, while return on assets reaches 12.2%, both solid metrics for a manufacturing business.
Growth has accelerated recently. Full-year 2024 results showed 17.3% revenue growth, 32% gross profit growth, and 30.2% net income growth. Earnings per share jumped 26.7% year-over-year. The company’s operating margin improved to 25%, and net profit margin expanded to 20.9%. These metrics suggest management is executing well on cost control and operational efficiency. Receivables grew 37.7%, indicating strong demand for cleanroom and healthcare products.
Market Sentiment and Technical Indicators
Technical indicators suggest AP4.SI stock faces near-term headwinds. The RSI of 44.92 indicates neutral momentum, while the CCI of -124.69 signals oversold conditions. The Stochastic %K at 20.24 and Williams %R at -91.67 both point to oversold territory, potentially setting up a bounce.
Volume has been light at 1.29 million shares, representing just 39% of the 3.34 million average. The stock trades within Bollinger Bands, with the upper band at S$0.79 and lower band at S$0.72. The MACD histogram sits flat at zero, suggesting momentum is stalling. Money Flow Index at 18.10 confirms oversold conditions. These technical signals suggest traders may be positioning ahead of the May 13 earnings report, creating potential volatility around the announcement.
Meyka AI Rating and Price Forecast
Meyka AI rates AP4.SI with a grade of B, with a recommendation to HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects balanced risk-reward at current levels. These grades are not guaranteed and we are not financial advisors.
Meyka AI’s forecast model projects AP4.SI stock at S$0.72 for the next twelve months, implying 1.4% downside from current levels. The five-year forecast suggests S$0.32, indicating significant long-term pressure. However, the model’s bearish long-term view contrasts with strong recent earnings growth. Track AP4.SI on Meyka for real-time updates and revised forecasts post-earnings. Forecasts are model-based projections and not guarantees.
Final Thoughts
Riverstone Holdings Limited shows strong fundamentals with 17.3% revenue growth, 30.2% net income acceleration, and zero debt, but faces a 21.9% annual stock decline. The 11.7% dividend yield attracts income investors despite technical weakness. The May 13 earnings announcement will determine if the company can recover from its decline by clarifying 2026 guidance, margin sustainability, and capital allocation strategy. Investors should weigh solid operational performance against current market headwinds.
FAQs
Riverstone Holdings (AP4.SI) announces earnings on May 13, 2026 at 12:00 PM UTC on the Singapore Exchange, a key date for investors monitoring the healthcare glove manufacturer’s performance.
AP4.SI offers an 11.7% dividend yield with trailing twelve-month dividends of S$0.263 per share, reflecting strong cash generation and shareholder-friendly capital allocation.
Meyka AI rates AP4.SI with a B grade and HOLD recommendation. The stock trades at a reasonable PE of 14.6 with strong fundamentals, but investors should await earnings clarity.
Riverstone manufactures cleanroom and healthcare gloves, finger cots, face masks, and ESD consumables under the RS brand, serving semiconductor, healthcare, and related industries globally.
Meyka AI projects AP4.SI at S$0.72 in 12 months (1.4% downside) and S$0.32 in five years. Forecasts contrast with recent earnings growth and should be used cautiously.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)